Aptitude Extends Product Portfolio With IFRS 17
To equip insurance CFO’s who will need to act following this morning’s announcement by the International Accounting Standards Board (IASB), Aptitude Software announces the Aptitude IFRS 17 Solution.
The Aptitude solution will perform IFRS 17 calculations in line with what has been documented by the accounting regulator and addresses the range of processing and systems requirements captured via the company’s extensive market discussions.
IFRS 17 requires extensive changes to finance statements as well as the processes and systems insurance companies rely on to produce management information. As raised on this morning’s IASB webinar, insurance companies are concerned about implementation costs, data requirements, the levels of contract aggregation and the inherent requirement to enhance financial control in their accounting systems.
Aptitude’s specialist accounting product approach enables insurance companies to address the IFRS reporting requirements efficiently, reduce implementation cost and risk and achieve accounting best practice.
These benefits are delivered by plugging holes in insurance companies’ existing systems architectures. The Aptitude solution will embed IFRS 17 processes such as insurance contract portfolio management and P&L attribution, incorporates an ‘out of the box’ insurance data model and accounting templates, and leverages the depth and performance of Aptitude’s proven, packaged operational accounting platform.
Importantly the Aptitude approach delivers flexibility to support other accounting and regulatory reporting requirements, including IFRS 9 and IFRS 16.
“The onslaught of current accounting policy changes – including IFRS9,
IFRS 15, IFRS16, and IFRS17 – all require enterprises to realize control and account for granular contract detail in their business” says Ross E. Chapman, Aptitude Software’s Marketing Director.
“The Aptitude IFRS 17 solution will equip insurance finance teams with the foundation to address these requirements while improving control, transparency and insight over future accounting.”
The finalized IFRS 17 standard can be accessed via the following link: http://www.ifrs.org/Features/Pages/IFRS-17-insurance-contracts.aspx
For more information on the Aptitude IFRS 17 solution, please contact email@example.com
Join Aptitude Software at upcoming events
1 June 2017 – IFRS 17 Roundtable – Merchant Taylor’s Hall, London
Aptitude Software brings together industry experts to discuss the impact of IFRS 17 and how to develop strategies to deal with it. Join Deloitte, KPMG, AIG, RSA, L&G, HSBC Insurance, Direct Line and others.
RSVP to firstname.lastname@example.org
7 June 2017 – Data for InsuranceERM Event – Hilton Bankside, London
Aptitude Software will lead a discussion and panel about the impact of IFRS 17 on actuarial, data and finance systems. For inclusion in the panel, please contact email@example.com
About Aptitude Software
Aptitude Software delivers specialist enterprise finance applications to enable CFO’s to supercharge control, reporting and analysis.
The company’s software controls and automates high volume, complex accounting processes to provide solutions to problems that aren’t well served by legacy ERP and IT-centric approaches.
Our mission is to equip CFO’s to fulfill their strategies and ambitions.
Aptitude Software is a Microgen plc company (LSE: MCGN).
Copyright © Aptitude Software Inc. 2014-2017.
Microgen ® Microgen plc. Aptitude™ Aptitude Software Limited.
Aptitude IFRS 17 Solution™ Aptitude Software Limited
For more information:
Ross E. Chapman
+44 207 496 8100
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport18.7.2018 09:05 | Pressemelding
Smiths Detection has been selected by Finnish airport operator, Finavia Corporation, to support the transition to Standard 3 at Helsinki Airport with approved hold baggage screening systems. Included in the contract are eight high-speed, HI-SCAN 10080 XCT scanners, which combine high resolution X-ray technology, computed tomography (CT) and advanced detection algorithms to increase both security and operational efficiency significantly. Security, speed and efficiency are critical to the extensive development programme underway at the airport, which will allow the airport to serve 30 million passengers annually and increase baggage handling capacity by 50%. “Any financial investment in upgrading security equipment has to be balanced against operational improvement, particularly when part of a major expansion. Airports need assurance that efficiencies will be gained and systems can be further updated as necessary to detect evolving explosive threats and handle ever higher volumes,” comme
Norsk Titanium Continues to Grow in the State of New York18.7.2018 07:00 | Pressemelding
Norsk Titanium (Norsk), the world’s first FAA-approved supplier of aerospace-grade, additive manufactured, structural titanium components, announced another major milestone in qualified production. Norsk’s Plattsburgh Development and Qualification Center (PDQC) site was officially added to the Spirit AeroSystems Approved Suppliers List (ASL) in anticipation of the start of qualified production later this year. Partnered with the recent announcements of PDQC being added to the Boeing’s Qualified Producer’s List (QPL) list and its certification under AS9100D, this new qualification is key to furthering the availability of Norsk’s disruptive technology in the aerospace market. Spirit AeroSystems is the world’s largest independent aerostructures manufacturer. “These significant achievements have been made possible by the foresight and commitment made to Norsk by the State of New York and Empire State Development. We are extremely proud of our PDQC quality and operations teams and appreciat
The Best User Interface in Mobile and Web Tracking Just got Better18.7.2018 06:00 | Pressemelding
ThriveTracker, a leading web and mobile tracker for media buyers and performance marketers, today announced the general availability of its latest release featuring an all-new user interface (UI). Inspired by feedback from customers and partners, ThriveTracker designed the new UI to accelerate user adoption, improve usability and increase productivity. ThriveTracker focused on the user experience for all users regardless of device, (Desktop, Mobile, etc.), making it more intuitive and accessible. Improved navigation provides simplified access to frequently used functions in the platform, increases customer awareness of more advanced functionality and delivers fast access to detailed content when necessary. Cleaner, simpler, modern UI Clear, consistent navigation focuses your attention on where you are and what you can do Improved layout delivers common functions intuitively Simplified views provide faster access to relevant content Mobile Friendly Mobile responsive based on device New
EUSA Pharma Announces Acquisition of Global Rights to SYLVANT® (siltuximab) from Janssen Sciences Ireland UC for $115 Million18.7.2018 06:00 | Pressemelding
EUSA Pharma (EUSA), a biopharmaceutical company focused on oncology and rare disease, announced today that it has entered into a definitive agreement with Janssen Sciences Ireland UC, a subsidiary of Janssen R&D Ireland (Janssen) to acquire the global rights to SYLVANT® (siltuximab) for $115 million in cash. The transaction is subject to review under the United States Hart–Scott–Rodino Antitrust Improvements Act of 1976, as amended, and the parties expect to close following completion of this regulatory review period and the mutual satisfaction of other remaining closing conditions. SYLVANT® is approved in more than 40 countries worldwide, including the United States, the European Union, the Republic of Korea and Canada, for the treatment of idiopathic multicentric Castleman’s disease (iMCD), a rare, life threatening and debilitating orphan condition. Idiopathic MCD is an inflammatory lymphoproliferative disorder, which causes the abnormal overgrowth of immune cells and shares many sym
JPMorgan Chase Bank announces the placement of cash-settled exchangeable bonds into Ping An Insurance (Group) Company of China Limited due 202017.7.2018 19:40 | Pressemelding
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933) OR IN OR INTO JAPAN, THE PEOPLE’S REPUBLIC OF CHINA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. JPMorgan Chase Bank, N.A. (the “Issuer”) today announces the placement of cash-settled exchangeable bonds due 2020 (the “Bonds”) in aggregate principal amount of USD 350 million. The Bonds are referable to H-shares (the “Shares”) of Ping An Insurance (Group) Company of China Limited (the “Company”). Exchange rights in respect of the Bonds will be cash-settled only. The Bonds will be issued in principal amounts of USD 200,000 and integral multiples of USD 100,000 in excess thereof and will not bear interest. The Bonds will be issued with an issue price of 100% and will redeem at par on 30 December 2020. The initial exchange price (the “Initial Exchange Price”) will
Boston Capital Announces Closing of Boston Capital Income & Value U.S. Apartment Fund17.7.2018 14:00 | Pressemelding
Boston Capital, the third largest owner of apartments in the U.S. with over $19.6 billion invested, is pleased to announce the final investor closing of Boston Capital Income and Value U.S. Apartment Fund (“BCIV”). BCIV, a discretionary multi-investor Luxembourg based fund vehicle, includes financial institutions, insurance companies, pensions, and family offices among its investors and will acquire over $350 million in apartment properties throughout the U.S. “We are very pleased to close BCIV, the latest in a succession of institutional investment vehicles through Boston Capital’s conventional apartment investment arm, Boston Capital Real Estate Partners (“BCRE”),” said Jeff Goldstein, COO and Director of Real Estate at Boston Capital. The Fund generates high current dividends and capital growth by acquiring and renovating Class B apartment properties located in major and secondary U.S. markets and by targeting a renovated rental price point well below new construction rates, which a